Hyderabad, Oct. 6 -- Eli Lilly and company (doing business as Lilly), an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries, on Monday announced plans to invest more than $1 billion over the next several years into new contract manufacturing in India.
Lilly was the first company to mass-produce both the polio vaccine and it was also one of the first pharmaceutical companies to produce human insulin using recombinant DNA.
This strategic investment will further strengthen the manufacturing and supply capabilities to support our evolving portfolio, the company said in a release.
In addition, Lilly will establish a new manufacturing & quality presence in Hyderabad and this new h...